| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| HumanPheno | Linear nevus sebaceous | 5.61e-07 | 3 | 43 | 3 | HP:0010817 | |
| HumanPheno | Hemimegalencephaly | 4.15e-06 | 14 | 43 | 4 | HP:0007206 | |
| HumanPheno | Nevus sebaceous | 5.54e-06 | 5 | 43 | 3 | HP:0010815 | |
| HumanPheno | Adenoma sebaceum | 4.90e-05 | 25 | 43 | 4 | HP:0009720 | |
| HumanPheno | Hypophosphatemic rickets | 4.90e-05 | 25 | 43 | 4 | HP:0004912 | |
| HumanPheno | Angiofibromas | 1.03e-04 | 30 | 43 | 4 | HP:0010615 | |
| HumanPheno | Hyperphosphaturia | 1.03e-04 | 30 | 43 | 4 | HP:0003109 | |
| HumanPheno | Redundant skin | 1.05e-04 | 92 | 43 | 6 | HP:0001582 | |
| HumanPheno | Epidermal nevus | 1.17e-04 | 12 | 43 | 3 | HP:0010816 | |
| HumanPheno | Genu recurvatum | 1.70e-04 | 34 | 43 | 4 | HP:0002816 | |
| HumanPheno | Abnormal urine phosphate concentration | 1.91e-04 | 35 | 43 | 4 | HP:0012599 | |
| HumanPheno | Nevus spilus | 2.08e-04 | 3 | 43 | 2 | HP:0025510 | |
| Domain | ARM-type_fold | 1.25e-04 | 339 | 105 | 9 | IPR016024 | |
| Domain | PID_Shc-like | 1.86e-04 | 4 | 105 | 2 | IPR006019 | |
| Domain | DOCK_N | 3.10e-04 | 5 | 105 | 2 | PF16172 | |
| Domain | DOCK_N | 3.10e-04 | 5 | 105 | 2 | IPR032376 | |
| Domain | TPR-like_helical_dom | 3.47e-04 | 233 | 105 | 7 | IPR011990 | |
| Domain | Liprin | 4.63e-04 | 6 | 105 | 2 | IPR029515 | |
| Domain | RAS | 9.91e-04 | 35 | 105 | 3 | PS51421 | |
| Domain | Small_GTPase_Ras | 1.17e-03 | 37 | 105 | 3 | IPR020849 | |
| Domain | TPR-contain_dom | 1.58e-03 | 150 | 105 | 5 | IPR013026 | |
| Domain | DHR-1_domain | 1.67e-03 | 11 | 105 | 2 | IPR027007 | |
| Domain | DHR_2 | 1.67e-03 | 11 | 105 | 2 | PS51651 | |
| Domain | DHR_1 | 1.67e-03 | 11 | 105 | 2 | PS51650 | |
| Domain | DHR-2 | 1.67e-03 | 11 | 105 | 2 | PF06920 | |
| Domain | DOCK | 1.67e-03 | 11 | 105 | 2 | IPR026791 | |
| Domain | DOCK_C | 1.67e-03 | 11 | 105 | 2 | IPR010703 | |
| Domain | DOCK-C2 | 1.67e-03 | 11 | 105 | 2 | PF14429 | |
| Domain | DHR-2 | 1.67e-03 | 11 | 105 | 2 | IPR027357 | |
| Domain | TPR_REGION | 2.40e-03 | 165 | 105 | 5 | PS50293 | |
| Domain | TPR | 2.40e-03 | 165 | 105 | 5 | PS50005 | |
| Domain | TPR_8 | 3.30e-03 | 53 | 105 | 3 | PF13181 | |
| Domain | TPR | 6.07e-03 | 129 | 105 | 4 | SM00028 | |
| Domain | - | 6.29e-03 | 207 | 105 | 5 | 1.25.40.10 | |
| Pathway | REACTOME_SHC_MEDIATED_CASCADE_FGFR3 | 7.19e-08 | 18 | 89 | 5 | M27518 | |
| Pathway | REACTOME_ACTIVATED_NTRK3_SIGNALS_THROUGH_RAS | 1.02e-07 | 8 | 89 | 4 | M27919 | |
| Pathway | REACTOME_SHC_MEDIATED_CASCADE_FGFR4 | 1.29e-07 | 20 | 89 | 5 | M27524 | |
| Pathway | REACTOME_SHC_MEDIATED_CASCADE_FGFR1 | 1.68e-07 | 21 | 89 | 5 | M27511 | |
| Pathway | REACTOME_SHC_RELATED_EVENTS_TRIGGERED_BY_IGF1R | 1.83e-07 | 9 | 89 | 4 | M27173 | |
| Pathway | REACTOME_ACTIVATED_NTRK2_SIGNALS_THROUGH_RAS | 1.83e-07 | 9 | 89 | 4 | M27904 | |
| Pathway | REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR3 | 4.31e-07 | 25 | 89 | 5 | M27520 | |
| Pathway | REACTOME_SIGNALING_BY_NTRK2_TRKB | 4.31e-07 | 25 | 89 | 5 | M27864 | |
| Pathway | REACTOME_MET_ACTIVATES_RAS_SIGNALING | 4.74e-07 | 11 | 89 | 4 | M27740 | |
| Pathway | REACTOME_CONSTITUTIVE_SIGNALING_BY_OVEREXPRESSED_ERBB2 | 4.74e-07 | 11 | 89 | 4 | M29814 | |
| Pathway | REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR4 | 6.48e-07 | 27 | 89 | 5 | M27523 | |
| Pathway | WP_MAPK_CASCADE | 7.85e-07 | 28 | 89 | 5 | MM15976 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_JNK_SIGNALING_PATHWAY | 1.02e-06 | 13 | 89 | 4 | M47594 | |
| Pathway | REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR2 | 1.13e-06 | 30 | 89 | 5 | M27515 | |
| Pathway | REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR1 | 1.34e-06 | 31 | 89 | 5 | M27510 | |
| Pathway | REACTOME_SHC1_EVENTS_IN_ERBB4_SIGNALING | 1.42e-06 | 14 | 89 | 4 | M569 | |
| Pathway | REACTOME_ERYTHROPOIETIN_ACTIVATES_RAS | 1.42e-06 | 14 | 89 | 4 | M27908 | |
| Pathway | REACTOME_SHC1_EVENTS_IN_EGFR_SIGNALING | 1.42e-06 | 14 | 89 | 4 | M719 | |
| Pathway | WP_MAPK_CASCADE | 1.85e-06 | 33 | 89 | 5 | M39594 | |
| Pathway | WP_BDNFTRKB_SIGNALING | 1.85e-06 | 33 | 89 | 5 | M39532 | |
| Pathway | REACTOME_CONSTITUTIVE_SIGNALING_BY_EGFRVIII | 1.92e-06 | 15 | 89 | 4 | M29701 | |
| Pathway | REACTOME_ACTIVATION_OF_RAS_IN_B_CELLS | 2.41e-06 | 5 | 89 | 3 | M26921 | |
| Pathway | REACTOME_SIGNALING_BY_ERBB2_ECD_MUTANTS | 2.55e-06 | 16 | 89 | 4 | M29847 | |
| Pathway | REACTOME_FC_EPSILON_RECEPTOR_FCERI_SIGNALING | 2.56e-06 | 186 | 89 | 9 | M27175 | |
| Pathway | REACTOME_SHC_MEDIATED_CASCADE_FGFR3 | 3.32e-06 | 17 | 89 | 4 | MM15244 | |
| Pathway | REACTOME_SIGNALING_BY_NTRK3_TRKC | 3.32e-06 | 17 | 89 | 4 | M27918 | |
| Pathway | REACTOME_TIE2_SIGNALING | 4.25e-06 | 18 | 89 | 4 | M11932 | |
| Pathway | REACTOME_REGULATION_OF_RAS_BY_GAPS | 4.27e-06 | 68 | 89 | 6 | M27539 | |
| Pathway | REACTOME_ESTROGEN_STIMULATED_SIGNALING_THROUGH_PRKCZ | 4.80e-06 | 6 | 89 | 3 | M27951 | |
| Pathway | KEGG_MEDICUS_VARIANT_LOSS_OF_RASSF1_TO_RAS_RASSF1_SIGNALING_PATHWAY | 4.80e-06 | 6 | 89 | 3 | M47433 | |
| Pathway | KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_RAS_UBIQUITINATION_BY_CUL3_COMPLEX | 4.80e-06 | 6 | 89 | 3 | M47931 | |
| Pathway | KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_SPRED_AND_NF1 | 4.80e-06 | 6 | 89 | 3 | M47932 | |
| Pathway | REACTOME_SIGNALING_BY_FGFR3 | 4.95e-06 | 40 | 89 | 5 | M27532 | |
| Pathway | PID_ER_NONGENOMIC_PATHWAY | 4.95e-06 | 40 | 89 | 5 | M41 | |
| Pathway | REACTOME_SHC_MEDIATED_CASCADE_FGFR4 | 5.35e-06 | 19 | 89 | 4 | MM15250 | |
| Pathway | REACTOME_CONSTITUTIVE_SIGNALING_BY_LIGAND_RESPONSIVE_EGFR_CANCER_VARIANTS | 5.35e-06 | 19 | 89 | 4 | M559 | |
| Pathway | REACTOME_VEGFR2_MEDIATED_CELL_PROLIFERATION | 5.35e-06 | 19 | 89 | 4 | M27423 | |
| Pathway | REACTOME_SIGNALING_BY_FGFR4 | 5.61e-06 | 41 | 89 | 5 | M27533 | |
| Pathway | REACTOME_FRS_MEDIATED_FGFR3_SIGNALING | 6.66e-06 | 20 | 89 | 4 | M27519 | |
| Pathway | REACTOME_RAS_ACTIVATION_UPON_CA2_INFLUX_THROUGH_NMDA_RECEPTOR | 6.66e-06 | 20 | 89 | 4 | M17670 | |
| Pathway | REACTOME_SHC_MEDIATED_CASCADE_FGFR1 | 6.66e-06 | 20 | 89 | 4 | MM15237 | |
| Pathway | REACTOME_SIGNALLING_TO_RAS | 6.66e-06 | 20 | 89 | 4 | M12256 | |
| Pathway | REACTOME_SHC_MEDIATED_CASCADE_FGFR2 | 8.18e-06 | 21 | 89 | 4 | MM15242 | |
| Pathway | REACTOME_RAS_SIGNALING_DOWNSTREAM_OF_NF1_LOSS_OF_FUNCTION_VARIANTS | 8.36e-06 | 7 | 89 | 3 | M29717 | |
| Pathway | REACTOME_SOS_MEDIATED_SIGNALLING | 8.36e-06 | 7 | 89 | 3 | M19489 | |
| Pathway | WP_EFFECT_OF_OMEGA3_PUFA_ON_HUNTINGTONS_DISEASE_PATHWAYS | 9.95e-06 | 119 | 89 | 7 | M48309 | |
| Pathway | REACTOME_FRS_MEDIATED_FGFR4_SIGNALING | 9.95e-06 | 22 | 89 | 4 | M27522 | |
| Pathway | REACTOME_SHC1_EVENTS_IN_ERBB2_SIGNALING | 9.95e-06 | 22 | 89 | 4 | M26929 | |
| Pathway | REACTOME_DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR | 1.19e-05 | 81 | 89 | 6 | M595 | |
| Pathway | REACTOME_FRS_MEDIATED_FGFR1_SIGNALING | 1.20e-05 | 23 | 89 | 4 | M27513 | |
| Pathway | REACTOME_SIGNALING_BY_INSULIN_RECEPTOR | 1.27e-05 | 82 | 89 | 6 | M1021 | |
| Pathway | KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_RASGAP | 1.33e-05 | 8 | 89 | 3 | M47935 | |
| Pathway | WP_GLIOBLASTOMA_SIGNALING | 1.37e-05 | 83 | 89 | 6 | M39637 | |
| Pathway | REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR3 | 1.43e-05 | 24 | 89 | 4 | MM15246 | |
| Pathway | WP_SYNAPTIC_SIGNALING_ASSOCIATED_WITH_AUTISM_SPECTRUM_DISORDER | 1.52e-05 | 50 | 89 | 5 | M39822 | |
| Pathway | REACTOME_FRS_MEDIATED_FGFR2_SIGNALING | 1.70e-05 | 25 | 89 | 4 | M27517 | |
| Pathway | REACTOME_SIGNALING_BY_EGFR_IN_CANCER | 1.70e-05 | 25 | 89 | 4 | M563 | |
| Pathway | REACTOME_SIGNALING_BY_ERYTHROPOIETIN | 1.70e-05 | 25 | 89 | 4 | M27865 | |
| Pathway | KEGG_ERBB_SIGNALING_PATHWAY | 1.79e-05 | 87 | 89 | 6 | M12467 | |
| Pathway | REACTOME_SIGNALING_BY_FGFR1 | 1.84e-05 | 52 | 89 | 5 | M27530 | |
| Pathway | REACTOME_EGFR_TRANSACTIVATION_BY_GASTRIN | 1.99e-05 | 9 | 89 | 3 | M27156 | |
| Pathway | REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR4 | 2.00e-05 | 26 | 89 | 4 | MM15249 | |
| Pathway | REACTOME_SIGNALING_BY_ERBB2_IN_CANCER | 2.00e-05 | 26 | 89 | 4 | M29535 | |
| Pathway | REACTOME_SIGNALING_BY_TYPE_1_INSULIN_LIKE_GROWTH_FACTOR_1_RECEPTOR_IGF1R | 2.22e-05 | 54 | 89 | 5 | M27168 | |
| Pathway | REACTOME_INSULIN_RECEPTOR_SIGNALLING_CASCADE | 2.22e-05 | 54 | 89 | 5 | M620 | |
| Pathway | WP_ERBB_SIGNALING | 2.46e-05 | 92 | 89 | 6 | M39715 | |
| Pathway | REACTOME_CREB1_PHOSPHORYLATION_THROUGH_NMDA_RECEPTOR_MEDIATED_ACTIVATION_OF_RAS_SIGNALING | 2.71e-05 | 28 | 89 | 4 | M837 | |
| Pathway | REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR2 | 2.71e-05 | 28 | 89 | 4 | MM15241 | |
| Pathway | REACTOME_MET_ACTIVATES_RAS_SIGNALING | 2.83e-05 | 10 | 89 | 3 | MM15488 | |
| Pathway | REACTOME_C_TYPE_LECTIN_RECEPTORS_CLRS | 2.87e-05 | 140 | 89 | 7 | M27484 | |
| Pathway | REACTOME_DAP12_SIGNALING | 3.12e-05 | 29 | 89 | 4 | M27171 | |
| Pathway | REACTOME_SIGNALING_BY_ERBB4 | 3.15e-05 | 58 | 89 | 5 | M544 | |
| Pathway | PID_RAS_PATHWAY | 3.59e-05 | 30 | 89 | 4 | M269 | |
| Pathway | REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR1 | 3.59e-05 | 30 | 89 | 4 | MM15236 | |
| Pathway | REACTOME_BETA_CATENIN_INDEPENDENT_WNT_SIGNALING | 3.75e-05 | 146 | 89 | 7 | M27288 | |
| Pathway | REACTOME_SIGNALING_BY_FGFR4_IN_DISEASE | 3.87e-05 | 11 | 89 | 3 | M27535 | |
| Pathway | KEGG_MEDICUS_VARIANT_RET_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY | 3.87e-05 | 11 | 89 | 3 | M47370 | |
| Pathway | KEGG_MEDICUS_VARIANT_TRK_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY | 3.87e-05 | 11 | 89 | 3 | M47371 | |
| Pathway | REACTOME_ACTIVATED_NTRK2_SIGNALS_THROUGH_FRS2_AND_FRS3 | 3.87e-05 | 11 | 89 | 3 | M27911 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_RALGDS_SIGNALING_PATHWAY | 3.87e-05 | 11 | 89 | 3 | M47436 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_RASSF1_SIGNALING_PATHWAY | 3.87e-05 | 11 | 89 | 3 | M47432 | |
| Pathway | REACTOME_SHC1_EVENTS_IN_ERBB4_SIGNALING | 3.87e-05 | 11 | 89 | 3 | MM14533 | |
| Pathway | KEGG_GNRH_SIGNALING_PATHWAY | 4.19e-05 | 101 | 89 | 6 | M1979 | |
| Pathway | REACTOME_FC_EPSILON_RECEPTOR_FCERI_SIGNALING | 4.46e-05 | 150 | 89 | 7 | MM14889 | |
| Pathway | WP_PI3KAKTMTOR_SIGNALING_AND_THERAPEUTIC_OPPORTUNITIES_IN_PROSTATE_CANCER | 4.66e-05 | 32 | 89 | 4 | M39445 | |
| Pathway | REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES | 5.06e-05 | 270 | 89 | 9 | M15514 | |
| Pathway | KEGG_MEDICUS_VARIANT_EML4_ALK_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY | 5.14e-05 | 12 | 89 | 3 | M47369 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_METALS_TO_RAS_ERK_SIGNALING_PATHWAY | 5.14e-05 | 12 | 89 | 3 | M47815 | |
| Pathway | REACTOME_SIGNALLING_TO_RAS | 5.14e-05 | 12 | 89 | 3 | MM14657 | |
| Pathway | REACTOME_SIGNALING_BY_PDGFRA_TRANSMEMBRANE_JUXTAMEMBRANE_AND_KINASE_DOMAIN_MUTANTS | 5.14e-05 | 12 | 89 | 3 | M29851 | |
| Pathway | WP_RALA_DOWNSTREAM_REGULATED_GENES | 5.14e-05 | 12 | 89 | 3 | M39408 | |
| Pathway | WP_BREAST_CANCER_PATHWAY | 5.27e-05 | 154 | 89 | 7 | M39739 | |
| Pathway | KEGG_GLIOMA | 5.49e-05 | 65 | 89 | 5 | M1835 | |
| Pathway | REACTOME_REGULATION_OF_RAS_BY_GAPS | 5.91e-05 | 66 | 89 | 5 | MM15261 | |
| Pathway | REACTOME_SIGNALLING_TO_ERKS | 5.96e-05 | 34 | 89 | 4 | M13881 | |
| Pathway | WP_THERMOGENESIS | 6.10e-05 | 108 | 89 | 6 | M39746 | |
| Pathway | REACTOME_SHC1_EVENTS_IN_EGFR_SIGNALING | 6.65e-05 | 13 | 89 | 3 | MM14701 | |
| Pathway | REACTOME_P38MAPK_EVENTS | 6.65e-05 | 13 | 89 | 3 | M1441 | |
| Pathway | KEGG_MEDICUS_REFERENCE_FGF_FGFR_RAS_ERK_SIGNALING_PATHWAY | 6.69e-05 | 35 | 89 | 4 | M47379 | |
| Pathway | PID_ERBB1_RECEPTOR_PROXIMAL_PATHWAY | 6.69e-05 | 35 | 89 | 4 | M127 | |
| Pubmed | Organization and evolutionary relatedness of OR37 olfactory receptor genes in mouse and human. | 3.51e-18 | 12 | 109 | 8 | 12906860 | |
| Pubmed | 3.17e-09 | 7 | 109 | 4 | 20179099 | ||
| Pubmed | 3.17e-09 | 7 | 109 | 4 | 9690470 | ||
| Pubmed | Diagnostic Value of RAS Mutations in Indeterminate Thyroid Nodules. | 2.99e-08 | 3 | 109 | 3 | 28116986 | |
| Pubmed | RAS gene mutations and histomorphometric measurements in oral squamous cell carcinoma. | 2.99e-08 | 3 | 109 | 3 | 37013448 | |
| Pubmed | Mutations of RAS gene family in specimens of bladder cancer. | 2.99e-08 | 3 | 109 | 3 | 19101897 | |
| Pubmed | 2.99e-08 | 3 | 109 | 3 | 25977330 | ||
| Pubmed | 2.99e-08 | 3 | 109 | 3 | 33620658 | ||
| Pubmed | 2.99e-08 | 3 | 109 | 3 | 22589270 | ||
| Pubmed | A requirement for wild-type Ras isoforms in mutant KRas-driven signalling and transformation. | 2.99e-08 | 3 | 109 | 3 | 23496764 | |
| Pubmed | Distribution of p21ras during primary palate formation of non-cleft and cleft strains of mice. | 2.99e-08 | 3 | 109 | 3 | 7776260 | |
| Pubmed | 2.99e-08 | 3 | 109 | 3 | 28630043 | ||
| Pubmed | Overexpression of wild-type p21Ras plays a prominent role in colorectal cancer. | 2.99e-08 | 3 | 109 | 3 | 28259994 | |
| Pubmed | The variable phenotype and low-risk nature of RAS-positive thyroid nodules. | 2.99e-08 | 3 | 109 | 3 | 26253102 | |
| Pubmed | 2.99e-08 | 3 | 109 | 3 | 16573741 | ||
| Pubmed | 2.99e-08 | 3 | 109 | 3 | 25788415 | ||
| Pubmed | Analysis of k-ras nuclear expression in fibroblasts and mesangial cells. | 2.99e-08 | 3 | 109 | 3 | 20090846 | |
| Pubmed | Comparison of liver oncogenic potential among human RAS isoforms. | 2.99e-08 | 3 | 109 | 3 | 26799184 | |
| Pubmed | 2.99e-08 | 3 | 109 | 3 | 21737741 | ||
| Pubmed | 2.99e-08 | 3 | 109 | 3 | 31906952 | ||
| Pubmed | Partial functional overlap of the three ras genes in mouse embryonic development. | 2.99e-08 | 3 | 109 | 3 | 18059342 | |
| Pubmed | Evidence of a low prevalence of RAS mutations in a large medullary thyroid cancer series. | 2.99e-08 | 3 | 109 | 3 | 23240926 | |
| Pubmed | 2.99e-08 | 3 | 109 | 3 | 24006476 | ||
| Pubmed | 2.99e-08 | 3 | 109 | 3 | 17943694 | ||
| Pubmed | Absolute Quantification of Endogenous Ras Isoform Abundance. | 2.99e-08 | 3 | 109 | 3 | 26560143 | |
| Pubmed | Further evidence for a somatic KRAS mutation in a pilocytic astrocytoma. | 2.99e-08 | 3 | 109 | 3 | 17712732 | |
| Pubmed | 2.99e-08 | 3 | 109 | 3 | 24222113 | ||
| Pubmed | 2.99e-08 | 3 | 109 | 3 | 28202657 | ||
| Pubmed | Mutational analysis of K-ras and Ras protein expression in larynx squamous cell carcinoma. | 2.99e-08 | 3 | 109 | 3 | 16761621 | |
| Pubmed | Interactions between wild-type and mutant Ras genes in lung and skin carcinogenesis. | 2.99e-08 | 3 | 109 | 3 | 22945650 | |
| Pubmed | 2.99e-08 | 3 | 109 | 3 | 19303097 | ||
| Pubmed | 2.99e-08 | 3 | 109 | 3 | 27911734 | ||
| Pubmed | Absence of oncogenic mutations of RAS family genes in soft tissue sarcomas of 100 Japanese patients. | 2.99e-08 | 3 | 109 | 3 | 20150643 | |
| Pubmed | 2.99e-08 | 3 | 109 | 3 | 20971740 | ||
| Pubmed | 2.99e-08 | 3 | 109 | 3 | 27119512 | ||
| Pubmed | K-ras is an essential gene in the mouse with partial functional overlap with N-ras. | 2.99e-08 | 3 | 109 | 3 | 9334313 | |
| Pubmed | The RAS-Effector Interface: Isoform-Specific Differences in the Effector Binding Regions. | 1.20e-07 | 4 | 109 | 3 | 27936046 | |
| Pubmed | Reducing Pericyte-Derived Scarring Promotes Recovery after Spinal Cord Injury. | 1.20e-07 | 4 | 109 | 3 | 29502968 | |
| Pubmed | Activated Ras interacts with the Ral guanine nucleotide dissociation stimulator. | 1.20e-07 | 4 | 109 | 3 | 7972015 | |
| Pubmed | 1.20e-07 | 4 | 109 | 3 | 10490827 | ||
| Pubmed | Tyrosine phosphorylation of RAS by ABL allosterically enhances effector binding. | 1.20e-07 | 4 | 109 | 3 | 25999467 | |
| Pubmed | 1.20e-07 | 4 | 109 | 3 | 10085069 | ||
| Pubmed | 1.20e-07 | 4 | 109 | 3 | 38849523 | ||
| Pubmed | 1.20e-07 | 4 | 109 | 3 | 34948093 | ||
| Pubmed | 1.20e-07 | 4 | 109 | 3 | 9674433 | ||
| Pubmed | Ras membrane orientation and nanodomain localization generate isoform diversity. | 1.20e-07 | 4 | 109 | 3 | 20080631 | |
| Pubmed | Quantification of spatiotemporal patterns of Ras isoform expression during development. | 1.20e-07 | 4 | 109 | 3 | 28117393 | |
| Pubmed | 2.98e-07 | 5 | 109 | 3 | 22982107 | ||
| Pubmed | Pericyte-derived fibrotic scarring is conserved across diverse central nervous system lesions. | 2.98e-07 | 5 | 109 | 3 | 34535655 | |
| Pubmed | 2.98e-07 | 5 | 109 | 3 | 17540175 | ||
| Pubmed | 2.98e-07 | 5 | 109 | 3 | 9069260 | ||
| Pubmed | Impeded Nedd4-1-mediated Ras degradation underlies Ras-driven tumorigenesis. | 2.98e-07 | 5 | 109 | 3 | 24746824 | |
| Pubmed | Activated Ras induces lens epithelial cell hyperplasia but not premature differentiation. | 2.98e-07 | 5 | 109 | 3 | 15558479 | |
| Pubmed | 4.72e-07 | 92 | 109 | 6 | 35530310 | ||
| Pubmed | 5.95e-07 | 6 | 109 | 3 | 9753431 | ||
| Pubmed | 5.95e-07 | 6 | 109 | 3 | 21072204 | ||
| Pubmed | 5.95e-07 | 6 | 109 | 3 | 10882715 | ||
| Pubmed | Glutamate transporter Slc1a3 mediates inter-niche stem cell activation during skin growth. | 5.95e-07 | 6 | 109 | 3 | 29615452 | |
| Pubmed | LZTR1 facilitates polyubiquitination and degradation of RAS-GTPases. | 5.95e-07 | 6 | 109 | 3 | 31337872 | |
| Pubmed | 1.04e-06 | 7 | 109 | 3 | 19487299 | ||
| Pubmed | 1.04e-06 | 7 | 109 | 3 | 20526288 | ||
| Pubmed | 1.04e-06 | 7 | 109 | 3 | 20012784 | ||
| Pubmed | 1.04e-06 | 7 | 109 | 3 | 12054535 | ||
| Pubmed | Impaired Proteolysis of Noncanonical RAS Proteins Drives Clonal Hematopoietic Transformation. | 1.04e-06 | 7 | 109 | 3 | 35904492 | |
| Pubmed | SmgGDS displays differential binding and exchange activity towards different Ras isoforms. | 1.04e-06 | 7 | 109 | 3 | 11948427 | |
| Pubmed | 1.04e-06 | 7 | 109 | 3 | 20860430 | ||
| Pubmed | 1.04e-06 | 7 | 109 | 3 | 22199277 | ||
| Pubmed | Human Sos1: a guanine nucleotide exchange factor for Ras that binds to GRB2. | 1.10e-06 | 25 | 109 | 4 | 8493579 | |
| Pubmed | Nerve growth factor signaling, neuroprotection, and neural repair. | 1.29e-06 | 26 | 109 | 4 | 11520933 | |
| Pubmed | 1.66e-06 | 8 | 109 | 3 | 15064703 | ||
| Pubmed | Genetic analysis of Ras signalling pathways in cell proliferation, migration and survival. | 1.66e-06 | 8 | 109 | 3 | 20150892 | |
| Pubmed | ATP6V1A MAP2K4 TCP1 PPFIA4 PPFIA1 PSMD2 PLEKHG5 VIRMA ADD1 ITPKB ITPR2 WDR47 GPD1L PSMD6 TTC7B KIF2A UTRN | 2.29e-06 | 1431 | 109 | 17 | 37142655 | |
| Pubmed | 2.48e-06 | 9 | 109 | 3 | 9344703 | ||
| Pubmed | 2.48e-06 | 9 | 109 | 3 | 10783161 | ||
| Pubmed | 3.54e-06 | 10 | 109 | 3 | 34215617 | ||
| Pubmed | Desmoplakin maintains gap junctions by inhibiting Ras/MAPK and lysosomal degradation of connexin-43. | 3.54e-06 | 10 | 109 | 3 | 29959233 | |
| Pubmed | SHANK proteins limit integrin activation by directly interacting with Rap1 and R-Ras. | 4.85e-06 | 11 | 109 | 3 | 28263956 | |
| Pubmed | TCP1 PPFIA1 SHC1 PSMD2 PTPRU BCOR ITPR2 PSMD6 PPP2R3A TTC7B CCNB2 DNAJA1 UTRN HELLS | 5.30e-06 | 1049 | 109 | 14 | 27880917 | |
| Pubmed | 6.45e-06 | 12 | 109 | 3 | 9269777 | ||
| Pubmed | 6.45e-06 | 12 | 109 | 3 | 22315970 | ||
| Pubmed | Ras effectors and their role in mitogenesis and oncogenesis. | 6.45e-06 | 12 | 109 | 3 | 9297626 | |
| Pubmed | Liprins, a family of LAR transmembrane protein-tyrosine phosphatase-interacting proteins. | 6.45e-06 | 12 | 109 | 3 | 9624153 | |
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 19789336 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 16624289 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 27698462 | ||
| Pubmed | Frequent KRAS and HRAS mutations in squamous cell papillomas of the head and neck. | 9.73e-06 | 2 | 109 | 2 | 31960612 | |
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 1970154 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 20188103 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 33053566 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 33544116 | ||
| Pubmed | Ras gene mutations in patients with acute myeloid leukaemia and exposure to chemical agents. | 9.73e-06 | 2 | 109 | 2 | 14688017 | |
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 20371679 | ||
| Pubmed | The prominent pervasive oncogenic role and tissue specific permissiveness of RAS gene mutations. | 9.73e-06 | 2 | 109 | 2 | 39455841 | |
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 26049686 | ||
| Pubmed | Common KRAS and NRAS gene mutations in sporadic colorectal cancer in Northeastern Iranian patients. | 9.73e-06 | 2 | 109 | 2 | 29921458 | |
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 28939768 | ||
| Pubmed | Lack of noncanonical RAS mutations in cytogenetically normal acute myeloid leukemia. | 9.73e-06 | 2 | 109 | 2 | 24737308 | |
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 17210246 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 39273371 | ||
| Pubmed | 9.73e-06 | 2 | 109 | 2 | 25009008 | ||
| Interaction | PSMD5 interactions | 1.09e-08 | 120 | 103 | 9 | int:PSMD5 | |
| Interaction | PSMD13 interactions | KRAS PPFIA1 PSMB6 NAPA PSMD2 PTPRU VIRMA RNF11 PSMD6 DNAJA1 RAD23A | 4.77e-07 | 306 | 103 | 11 | int:PSMD13 |
| Interaction | HEPH interactions | 2.56e-06 | 6 | 103 | 3 | int:HEPH | |
| Interaction | PSMD8 interactions | 4.34e-06 | 182 | 103 | 8 | int:PSMD8 | |
| Interaction | SLC23A2 interactions | 5.29e-06 | 23 | 103 | 4 | int:SLC23A2 | |
| Interaction | PDLIM4 interactions | 1.03e-05 | 27 | 103 | 4 | int:PDLIM4 | |
| Interaction | PSMD11 interactions | KRAS PPFIA1 PSMB6 NAPA PSMD2 VIRMA RNF11 PSMD6 DNAJA1 RAD23A | 1.33e-05 | 353 | 103 | 10 | int:PSMD11 |
| Interaction | PSMB2 interactions | 1.37e-05 | 213 | 103 | 8 | int:PSMB2 | |
| Interaction | TRPV2 interactions | 1.52e-05 | 10 | 103 | 3 | int:TRPV2 | |
| Interaction | PSMD1 interactions | KRAS TCP1 PPFIA1 PSMB6 PSMD2 PTPRU VIRMA RNF11 PSMD6 EMC2 RAD23A | 1.62e-05 | 442 | 103 | 11 | int:PSMD1 |
| Interaction | WDR44 interactions | 1.64e-05 | 105 | 103 | 6 | int:WDR44 | |
| Interaction | SNTB1 interactions | 1.76e-05 | 63 | 103 | 5 | int:SNTB1 | |
| Interaction | PLCB1 interactions | 1.76e-05 | 63 | 103 | 5 | int:PLCB1 | |
| Interaction | CTDSP1 interactions | 1.83e-05 | 107 | 103 | 6 | int:CTDSP1 | |
| Interaction | HSPH1 interactions | FLT4 SHC1 ARFGEF1 PSMD2 VIRMA INKA2 ADD1 PSMD6 EMC2 DNAJA1 UTRN | 1.84e-05 | 448 | 103 | 11 | int:HSPH1 |
| Interaction | RPS27A interactions | KRAS RASGRF2 PSMB6 PSMD2 PRPF8 VIRMA RNF11 PSMD6 HRAS PAN2 RBM47 RAD23A | 1.88e-05 | 536 | 103 | 12 | int:RPS27A |
| Interaction | PSEN1 interactions | 2.17e-05 | 227 | 103 | 8 | int:PSEN1 | |
| Interaction | ITM2B interactions | 2.38e-05 | 112 | 103 | 6 | int:ITM2B | |
| Interaction | KATNIP interactions | 2.76e-05 | 12 | 103 | 3 | int:KATNIP | |
| Interaction | GTSF1 interactions | 2.76e-05 | 12 | 103 | 3 | int:GTSF1 | |
| Interaction | LIN7C interactions | 3.35e-05 | 119 | 103 | 6 | int:LIN7C | |
| Interaction | PSMD6 interactions | 3.62e-05 | 317 | 103 | 9 | int:PSMD6 | |
| Interaction | ATP1A1 interactions | KRAS ATP6V1A NRAS TCP1 PSMD2 PRPF8 VIRMA ADD1 TYRO3 HRAS EMC2 DNAJA1 | 3.74e-05 | 575 | 103 | 12 | int:ATP1A1 |
| Interaction | ITGB6 interactions | 4.53e-05 | 14 | 103 | 3 | int:ITGB6 | |
| Interaction | SPTAN1 interactions | KRAS NRAS PPFIA1 PSMB6 SHC1 VIRMA ADD1 HRAS PAN2 KIF2A DNAJA1 | 4.66e-05 | 496 | 103 | 11 | int:SPTAN1 |
| Interaction | RAPGEF6 interactions | 4.97e-05 | 78 | 103 | 5 | int:RAPGEF6 | |
| Interaction | DAG1 interactions | 6.51e-05 | 134 | 103 | 6 | int:DAG1 | |
| Interaction | NAV2 interactions | 6.81e-05 | 43 | 103 | 4 | int:NAV2 | |
| Interaction | PPFIBP2 interactions | 6.81e-05 | 43 | 103 | 4 | int:PPFIBP2 | |
| Interaction | ELMOD3 interactions | 6.92e-05 | 16 | 103 | 3 | int:ELMOD3 | |
| Interaction | SAMSN1 interactions | 6.92e-05 | 16 | 103 | 3 | int:SAMSN1 | |
| Interaction | ARFGEF2 interactions | 7.07e-05 | 136 | 103 | 6 | int:ARFGEF2 | |
| Interaction | SLC1A3 interactions | 7.50e-05 | 85 | 103 | 5 | int:SLC1A3 | |
| Interaction | PSMD14 interactions | KRAS TCP1 PSMB6 PSMD2 PRPF8 VIRMA RNF11 PSMD6 GLG1 DNAJA1 RAD23A | 8.02e-05 | 527 | 103 | 11 | int:PSMD14 |
| Interaction | CEP104 interactions | 9.34e-05 | 89 | 103 | 5 | int:CEP104 | |
| Interaction | RGL1 interactions | 1.00e-04 | 18 | 103 | 3 | int:RGL1 | |
| Interaction | PHLDB1 interactions | 1.14e-04 | 49 | 103 | 4 | int:PHLDB1 | |
| Interaction | GYPC interactions | 1.18e-04 | 19 | 103 | 3 | int:GYPC | |
| Interaction | HLA-A interactions | 1.19e-04 | 289 | 103 | 8 | int:HLA-A | |
| Interaction | SPTA1 interactions | 1.21e-04 | 94 | 103 | 5 | int:SPTA1 | |
| Interaction | PSME4 interactions | 1.27e-04 | 95 | 103 | 5 | int:PSME4 | |
| Interaction | DYNC1I2 interactions | 1.37e-04 | 295 | 103 | 8 | int:DYNC1I2 | |
| Interaction | SLC6A9 interactions | 1.39e-04 | 20 | 103 | 3 | int:SLC6A9 | |
| Interaction | SUSD5 interactions | 1.39e-04 | 20 | 103 | 3 | int:SUSD5 | |
| Interaction | PLCE1 interactions | 1.39e-04 | 20 | 103 | 3 | int:PLCE1 | |
| Interaction | PRMT5 interactions | 1.50e-04 | 471 | 103 | 10 | int:PRMT5 | |
| Interaction | PIK3C2G interactions | 1.54e-04 | 4 | 103 | 2 | int:PIK3C2G | |
| Interaction | EPN2 interactions | 1.55e-04 | 99 | 103 | 5 | int:EPN2 | |
| Interaction | PLCB3 interactions | 1.70e-04 | 101 | 103 | 5 | int:PLCB3 | |
| Interaction | PSMD3 interactions | 1.76e-04 | 390 | 103 | 9 | int:PSMD3 | |
| Interaction | RAP2C interactions | 1.80e-04 | 55 | 103 | 4 | int:RAP2C | |
| Interaction | TTC21B interactions | 1.86e-04 | 22 | 103 | 3 | int:TTC21B | |
| Interaction | NECTIN1 interactions | 1.86e-04 | 22 | 103 | 3 | int:NECTIN1 | |
| Interaction | SEMA4C interactions | 1.91e-04 | 163 | 103 | 6 | int:SEMA4C | |
| Interaction | PSMA4 interactions | 1.92e-04 | 310 | 103 | 8 | int:PSMA4 | |
| Interaction | STXBP3 interactions | 1.95e-04 | 104 | 103 | 5 | int:STXBP3 | |
| Interaction | PTPRF interactions | 1.95e-04 | 233 | 103 | 7 | int:PTPRF | |
| Interaction | PSMB8 interactions | 2.04e-04 | 105 | 103 | 5 | int:PSMB8 | |
| Interaction | MPDZ interactions | 2.22e-04 | 107 | 103 | 5 | int:MPDZ | |
| Interaction | ABL2 interactions | 2.22e-04 | 107 | 103 | 5 | int:ABL2 | |
| Interaction | PTK7 interactions | 2.25e-04 | 168 | 103 | 6 | int:PTK7 | |
| Interaction | ANKRD50 interactions | 2.32e-04 | 108 | 103 | 5 | int:ANKRD50 | |
| Interaction | PIK3CG interactions | 2.36e-04 | 59 | 103 | 4 | int:PIK3CG | |
| Interaction | MARVELD2 interactions | 2.52e-04 | 60 | 103 | 4 | int:MARVELD2 | |
| Interaction | PSMB6 interactions | 2.52e-04 | 243 | 103 | 7 | int:PSMB6 | |
| Interaction | BMPR2 interactions | 2.53e-04 | 110 | 103 | 5 | int:BMPR2 | |
| Interaction | USP6NL interactions | 2.53e-04 | 110 | 103 | 5 | int:USP6NL | |
| Interaction | SLITRK2 interactions | 2.56e-04 | 5 | 103 | 2 | int:SLITRK2 | |
| Interaction | LRRC37A interactions | 2.56e-04 | 5 | 103 | 2 | int:LRRC37A | |
| Interaction | PIK3R1 interactions | 2.64e-04 | 412 | 103 | 9 | int:PIK3R1 | |
| Interaction | HSP90AB2P interactions | 2.64e-04 | 111 | 103 | 5 | int:HSP90AB2P | |
| Interaction | STXBP6 interactions | 2.75e-04 | 25 | 103 | 3 | int:STXBP6 | |
| Interaction | TTC7A interactions | 2.75e-04 | 25 | 103 | 3 | int:TTC7A | |
| Interaction | ATP2B1 interactions | 2.78e-04 | 247 | 103 | 7 | int:ATP2B1 | |
| Interaction | SLC5A3 interactions | 2.86e-04 | 62 | 103 | 4 | int:SLC5A3 | |
| Interaction | CDKL5 interactions | 2.87e-04 | 113 | 103 | 5 | int:CDKL5 | |
| Interaction | UBIAD1 interactions | 2.99e-04 | 114 | 103 | 5 | int:UBIAD1 | |
| Interaction | PSMD12 interactions | 2.99e-04 | 331 | 103 | 8 | int:PSMD12 | |
| Interaction | EPHA2 interactions | KRAS FLT4 NRAS PPFIA1 SHC1 NAPA ADD1 TYRO3 SLC6A8 TTC7B HRAS UTRN | 3.04e-04 | 719 | 103 | 12 | int:EPHA2 |
| Interaction | LYN interactions | KRAS NRAS PPFIA1 SHC1 PRPF8 VIRMA ADD1 MSI2 SLC6A8 HRAS PAN2 UTRN | 3.08e-04 | 720 | 103 | 12 | int:LYN |
| Interaction | STX12 interactions | 3.22e-04 | 253 | 103 | 7 | int:STX12 | |
| Interaction | TAOK3 interactions | 3.23e-04 | 64 | 103 | 4 | int:TAOK3 | |
| Interaction | VCP interactions | KRAS ATP6V1A TCP1 PSMB6 NAPA PSMD2 PTPRU PRPF8 VIRMA RNF11 ADD1 PSMD6 EMC2 KDSR DNAJA1 METTL17 HELLS RAD23A | 3.28e-04 | 1435 | 103 | 18 | int:VCP |
| Interaction | USP7 interactions | DOCK3 KRAS ABCA1 PPFIA1 PSMB6 SHC1 PSMD2 BCOR PRPF8 PLEKHG5 VIRMA RNF11 INKA2 SLC6A8 KIF2A EMC2 UTRN | 3.41e-04 | 1313 | 103 | 17 | int:USP7 |
| Interaction | CACHD1 interactions | 3.43e-04 | 65 | 103 | 4 | int:CACHD1 | |
| Interaction | OGDH interactions | 3.46e-04 | 256 | 103 | 7 | int:OGDH | |
| Interaction | ROCK2 interactions | 3.46e-04 | 182 | 103 | 6 | int:ROCK2 | |
| Interaction | HYCC2 interactions | 3.47e-04 | 27 | 103 | 3 | int:HYCC2 | |
| Interaction | NHERF2 interactions | 3.56e-04 | 183 | 103 | 6 | int:NHERF2 | |
| Interaction | SCAMP3 interactions | 3.56e-04 | 183 | 103 | 6 | int:SCAMP3 | |
| Interaction | RAB21 interactions | 3.78e-04 | 120 | 103 | 5 | int:RAB21 | |
| Interaction | FAM78A interactions | 3.83e-04 | 6 | 103 | 2 | int:FAM78A | |
| Interaction | PSMC4 interactions | 3.87e-04 | 344 | 103 | 8 | int:PSMC4 | |
| Interaction | RGL2 interactions | 3.87e-04 | 28 | 103 | 3 | int:RGL2 | |
| Interaction | PSMD2 interactions | 3.92e-04 | 435 | 103 | 9 | int:PSMD2 | |
| Interaction | PSMA7 interactions | 3.97e-04 | 262 | 103 | 7 | int:PSMA7 | |
| Interaction | DCUN1D3 interactions | 4.30e-04 | 29 | 103 | 3 | int:DCUN1D3 | |
| Interaction | SLC35A2 interactions | 4.30e-04 | 29 | 103 | 3 | int:SLC35A2 | |
| Interaction | UBE3A interactions | 4.33e-04 | 441 | 103 | 9 | int:UBE3A | |
| Interaction | TMEM161A interactions | 4.55e-04 | 70 | 103 | 4 | int:TMEM161A | |
| Cytoband | 9q31.1 | 7.36e-12 | 41 | 109 | 7 | 9q31.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9q31 | 4.18e-08 | 137 | 109 | 7 | chr9q31 | |
| Cytoband | 9p13.3 | 3.21e-05 | 75 | 109 | 4 | 9p13.3 | |
| GeneFamily | Olfactory receptors, family 13 | 8.36e-12 | 23 | 84 | 7 | 162 | |
| GeneFamily | RAS type GTPase family | 3.96e-04 | 31 | 84 | 3 | 389 | |
| GeneFamily | Proteasome | 1.04e-03 | 43 | 84 | 3 | 690 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 2.03e-03 | 115 | 84 | 4 | 769 | |
| Coexpression | DING_LUNG_CANCER_MUTATED_RECURRENTLY | 1.27e-06 | 6 | 106 | 3 | M14019 | |
| Coexpression | KIM_ALL_DISORDERS_CALB1_CORR_UP | DOCK3 DOCK4 ATP6V1A MAP2K4 PSMB6 NAPA PRPF8 RNF11 WDR47 GPD1L DNAJA1 | 1.38e-05 | 547 | 106 | 11 | M2110 |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.71e-06 | 161 | 108 | 6 | 5fba13f0aa5002f7eefe219e2c6a07e163f1a50d | |
| ToppCell | control-Epithelial-Ionocyte|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.12e-06 | 165 | 108 | 6 | 5cfba9a46bd8ceeca74a6493057b4d38af6b06fe | |
| ToppCell | NS-control-d_0-4-Epithelial-Ionocyte|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.23e-06 | 166 | 108 | 6 | 6d9fb239f69ba519844f593c00d515e1aac4ff50 | |
| ToppCell | control-Epithelial-Ionocyte|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.46e-06 | 168 | 108 | 6 | 327b02f19f4a8607c033203824fdc60a1254331f | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.99e-06 | 179 | 108 | 6 | 666072c0e8448dbaec1683d18368ec2502453f90 | |
| ToppCell | facs-Lung-18m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.15e-06 | 180 | 108 | 6 | 67c5068b660cd5e727a665cefe3bd5f8ae887221 | |
| ToppCell | facs-Lung-18m-Endothelial-arterial_endothelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.48e-06 | 182 | 108 | 6 | ebc812ed3f25839ea25f76b952c463d79a8325b1 | |
| ToppCell | facs-Lung-18m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.48e-06 | 182 | 108 | 6 | 47ff6b4002a4167412c79210651316d1342503f9 | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.21e-06 | 186 | 108 | 6 | 5302399825f213d105ac70b91366a4513b732838 | |
| ToppCell | COVID-19-kidney-DCT|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.60e-06 | 188 | 108 | 6 | 1d56cd409793f05cca20757ab26e91f1a1ee67b5 | |
| ToppCell | RV-09._Endothelium_I|World / Chamber and Cluster_Paper | 7.67e-06 | 193 | 108 | 6 | e3fa47e2c7cd8a5b69186711c57751f2296de8ae | |
| ToppCell | RV-09._Endothelium_I|RV / Chamber and Cluster_Paper | 7.90e-06 | 194 | 108 | 6 | 7b408096e717f2327c12aea35a8d5fc4621d3b06 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Pericyte-Muscle_pericyte_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.62e-06 | 197 | 108 | 6 | f66945f9007d59d4208849c7fd727f8519713fbc | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.11e-05 | 137 | 108 | 5 | 85b3a98039c1f68addad0334aa5b2584f6045aaa | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.43e-05 | 160 | 108 | 5 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.43e-05 | 160 | 108 | 5 | 8bcdbcfdf1e0ace6053e8de82762f6e2f86bba7a | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.43e-05 | 160 | 108 | 5 | 2d391ba6f7adb55dfa89feecc10cc9ce97e5fe74 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.43e-05 | 160 | 108 | 5 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | Bronchial_Brush-Epithelial-Ionocytes|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 6.42e-05 | 173 | 108 | 5 | f2a8f4918c1fb68d98bc3f33cd624de0f0f11e06 | |
| ToppCell | Bronchial_Biopsy-Epithelial-Ionocytes|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 6.60e-05 | 174 | 108 | 5 | 7e7b13de916cd4fa0fa6fb06e6b4942877afa9fb | |
| ToppCell | Bronchial_Biopsy-Epithelial-Ionocytes|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 6.78e-05 | 175 | 108 | 5 | 13b8f7dc38c90b74d4a20a84a8705d8e2ec244f6 | |
| ToppCell | NS-moderate-d_0-4-Epithelial-Ionocyte|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.78e-05 | 175 | 108 | 5 | a1e0a15c69211d6db2edeb101476f0f6e08b90c8 | |
| ToppCell | E18.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.78e-05 | 175 | 108 | 5 | 711ace94fa9a763c6ae48171a690953f25deebe4 | |
| ToppCell | kidney_cells-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.15e-05 | 177 | 108 | 5 | 227d4f423b00be2e0c5797e2c5275d342e69a0f4 | |
| ToppCell | kidney_cells-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.15e-05 | 177 | 108 | 5 | 66ffa279147961080c104242a08b176e301d80e3 | |
| ToppCell | kidney_cells-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.15e-05 | 177 | 108 | 5 | 0cbf54608d2ba0a0500af142f2029fe5e118c3c2 | |
| ToppCell | droplet-Lung-LUNG-30m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.54e-05 | 179 | 108 | 5 | a09647750eba9d93c5efc1db3b555fefb5eec7b5 | |
| ToppCell | COVID-19-Epithelial-Ionocytes|Epithelial / Condition, Lineage and Cell class | 7.95e-05 | 181 | 108 | 5 | 4a8d4f2709c1b25f908867f1b2fae1d2d0abf1d4 | |
| ToppCell | droplet-Heart-nan-3m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.95e-05 | 181 | 108 | 5 | 92d44892bb15771f0ab5fe61879b204b0acbd9b3 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.95e-05 | 181 | 108 | 5 | e0abf2707d9e0aa942c657eef7d2cbcd02f060dd | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_proliferating-Lymphatic_EC_proliferating_L.2.5.4.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.16e-05 | 182 | 108 | 5 | f703963b5d1e8c1f95d78807521048553b0792d8 | |
| ToppCell | cellseq-Epithelial-Epithelial_Neuro-Secretory-Ionocyte|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.16e-05 | 182 | 108 | 5 | 6e7dac78dc030f74e546b9f6db07556e9bb13ac2 | |
| ToppCell | droplet-Heart-nan-3m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.16e-05 | 182 | 108 | 5 | 81279877b920b5a1bc991a07d3031d6458700fe3 | |
| ToppCell | droplet-Lung-21m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.16e-05 | 182 | 108 | 5 | c7f2d24697affa530b748ab32b1d40bdc1bdc20a | |
| ToppCell | droplet-Lung-21m-Endothelial-arterial_endothelial|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.16e-05 | 182 | 108 | 5 | d95635b74e8cd8bc00bfe40340806b59fb9bee43 | |
| ToppCell | facs-Lung-Endomucin-3m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.16e-05 | 182 | 108 | 5 | aa113a0d2c1d28bda24cbb1221afd21b5628dc6d | |
| ToppCell | cellseq-Epithelial-Epithelial_Neuro-Secretory-Ionocyte-Ionocyte|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.16e-05 | 182 | 108 | 5 | cd972d30519db706477c6b0c901165b81b74abed | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_proliferating|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.16e-05 | 182 | 108 | 5 | ebd177ad5eac51bf2db0657596618bdf1e5d46e1 | |
| ToppCell | droplet-Lung-30m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.37e-05 | 183 | 108 | 5 | 6f8f997ffc9eaebca2683de125b6069d07c07d26 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.37e-05 | 183 | 108 | 5 | 2f0ee40e69ad1259e56e8ee4b352736900eb8901 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.37e-05 | 183 | 108 | 5 | 3c516fe5083f02bad1f464ed284010b4131a833c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.37e-05 | 183 | 108 | 5 | 9c2689d76fc6d30f5ab093428aa669d0a98953cf | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Neuro-endocrine/ionocytic-ionocyte-Ionocyte-Ionocyte_L.0.7.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.59e-05 | 184 | 108 | 5 | a60802e11dcc5f932811260b08a95a32f60f6b19 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.59e-05 | 184 | 108 | 5 | 688428103e8b19f45f2f65d70a0f30c904c8411c | |
| ToppCell | droplet-Lung-21m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.59e-05 | 184 | 108 | 5 | 087666ba949b129c53d7ace40f9e543e3875a7de | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Neuro-endocrine/ionocytic-ionocyte|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.59e-05 | 184 | 108 | 5 | 39c230d32e4259bc784e0edfd9e2884c96898564 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Neuro-endocrine/ionocytic-ionocyte-Ionocyte|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.59e-05 | 184 | 108 | 5 | 2a2fb691cc9414ef5b06c26239d2da03d6d7e5c2 | |
| ToppCell | droplet-Lung-30m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.59e-05 | 184 | 108 | 5 | f506d0ee48f39d6f59f19554217dfdf0987cc405 | |
| ToppCell | droplet-Lung-30m-Endothelial-arterial_endothelial|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.59e-05 | 184 | 108 | 5 | 8bcb1c4bc8ffef74338cdade926a94711de93c64 | |
| ToppCell | droplet-Lung-nan-21m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.04e-05 | 186 | 108 | 5 | 5d0cd07b6b51e8ce9e1da949f757dc4575ec5752 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.04e-05 | 186 | 108 | 5 | 888e85a025bd982d36c910db0f5a3385b1ca3b28 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.27e-05 | 187 | 108 | 5 | 65d406122dffe18279f14a1ed35ba091730b97be | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.27e-05 | 187 | 108 | 5 | 4c15c0ed41a55271fc793cb76fee97fa64190369 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.27e-05 | 187 | 108 | 5 | 5274f2b302bbf7fed30c480af4f35058d2cf61e0 | |
| ToppCell | P15-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_artery|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 9.50e-05 | 188 | 108 | 5 | 50b27fc12347ca16bd62333baf345c83cb422a8f | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.74e-05 | 189 | 108 | 5 | f51cdc9a47371cab8ed9ae63a6f14da07ede446c | |
| ToppCell | droplet-Lung-21m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.99e-05 | 190 | 108 | 5 | f50b9814a1beac67dc042a8c27dfd085ceeda3a6 | |
| ToppCell | droplet-Lung-21m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.99e-05 | 190 | 108 | 5 | a22a510b4a257eb0eaf09c7ae7978d3d2f07a58c | |
| ToppCell | (4)_Endothelial_cells-(40)_EC-arterial|(4)_Endothelial_cells / Cell class and subclass of bone marrow stroma cells in homeostatis | 9.99e-05 | 190 | 108 | 5 | ff774faf3f12759d11e50ed7d189288bb79e22e1 | |
| ToppCell | droplet-Lung-21m-Endothelial-lymphatic_endothelial|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.99e-05 | 190 | 108 | 5 | 57c136bf6d7feafb4a220877bed0cc8fdf314db2 | |
| ToppCell | PSB-critical-LOC-Epithelial-Ionocyte|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.02e-04 | 191 | 108 | 5 | 8f4637e801554e2343b974fe7794f01dd2151418 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.02e-04 | 191 | 108 | 5 | 1626b23a57429f835fddc052e3c57f63a4e5b8bb | |
| ToppCell | COVID-19-kidney-TAL|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.02e-04 | 191 | 108 | 5 | fe55475ce0666ab5122447a813dc2369e24947b8 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.02e-04 | 191 | 108 | 5 | 716dfa7fccbd62b5f574792e68a26dc6c45511dc | |
| ToppCell | COVID-19-kidney-AQP1+PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.05e-04 | 192 | 108 | 5 | 27ff3621e177e7932dd44dd6baa81551ea75a874 | |
| ToppCell | facs-Aorta-Heart-3m|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-04 | 192 | 108 | 5 | 1ccc47792edf9ee23501c8e2165d11271636b66a | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.07e-04 | 193 | 108 | 5 | 82e8a4c40299ffcdfd5a0da711bb9de6fb8a2eaa | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.07e-04 | 193 | 108 | 5 | 3866667dd221612589ae50f5c52f73a183a49ce6 | |
| ToppCell | EC-Arteriolar_ECs|EC / Lineage and Cell class | 1.13e-04 | 195 | 108 | 5 | fdb855d02ffac53dc0cc38792ce0ae5cb60b85ca | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.13e-04 | 195 | 108 | 5 | a38d9dc6192aea673d96fda6b25e81223fda3abf | |
| ToppCell | COVID-19-Heart-EC_1|Heart / Disease (COVID-19 only), tissue and cell type | 1.13e-04 | 195 | 108 | 5 | 50a193475db1bb1e05b8590225a553688c372c14 | |
| ToppCell | healthy_donor-Lymphocytic-T_cell-Gamma_Delta_T_cell|healthy_donor / Disease condition, Lineage, Cell class and subclass | 1.16e-04 | 196 | 108 | 5 | 6eabbac1625f715531bae562a28da27664572600 | |
| ToppCell | mild_COVID-19_(asymptomatic)|World / disease group, cell group and cell class (v2) | 1.16e-04 | 196 | 108 | 5 | 8cb3dcb3e5732f4bb060c87ca339b8997a1a8cd4 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Pericyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.18e-04 | 197 | 108 | 5 | 41dd312f46a2b983c8d864adeb6970c0ca4a8048 | |
| ToppCell | LV-09._Endothelium_I|LV / Chamber and Cluster_Paper | 1.18e-04 | 197 | 108 | 5 | f9731d4d636e51b94a96805eee6afe9aedc175e3 | |
| ToppCell | LAM-Endothelial-LymEndo|Endothelial / Condition, Lineage and Cell class | 1.21e-04 | 198 | 108 | 5 | ba64b1c95dfaa995045239d412e725596f6c482e | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Pericyte|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.27e-04 | 200 | 108 | 5 | d70bad979299615fcba707ba21296020918705e6 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Pericyte-Muscle_pericyte_pulmonary|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.27e-04 | 200 | 108 | 5 | 38c21ec379005f688df33aea65237a063c476c2e | |
| Drug | L 744832 | 3.80e-07 | 4 | 105 | 3 | ctd:C096898 | |
| Drug | Trimethobenzamide hydrochloride [554-92-7]; Down 200; 9.4uM; MCF7; HT_HG-U133A | 4.00e-06 | 199 | 105 | 8 | 1502_DN | |
| Drug | AC1L32OA | 7.85e-06 | 9 | 105 | 3 | CID000107745 | |
| Disease | Verrucous epidermal nevus | 4.25e-08 | 3 | 104 | 3 | C0362030 | |
| Disease | Nevus Sebaceus of Jadassohn | 4.25e-08 | 3 | 104 | 3 | C4552097 | |
| Disease | Organoid Nevus Phakomatosis | 4.25e-08 | 3 | 104 | 3 | C0265329 | |
| Disease | Linear nevus sebaceous syndrome | 4.25e-08 | 3 | 104 | 3 | cv:C4552097 | |
| Disease | Nevus sebaceous | 4.25e-08 | 3 | 104 | 3 | C3854181 | |
| Disease | Inflammatory linear verrucous epidermal nevus | 4.25e-08 | 3 | 104 | 3 | C0473574 | |
| Disease | SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME | 4.25e-08 | 3 | 104 | 3 | 163200 | |
| Disease | linear nevus sebaceous syndrome (is_implicated_in) | 4.25e-08 | 3 | 104 | 3 | DOID:0111530 (is_implicated_in) | |
| Disease | Noonan syndrome 3 (implicated_via_orthology) | 4.25e-08 | 3 | 104 | 3 | DOID:0060581 (implicated_via_orthology) | |
| Disease | Linear Verrucous Epidermal Nevus | 4.25e-08 | 3 | 104 | 3 | C3179502 | |
| Disease | cervical cancer (implicated_via_orthology) | 4.25e-08 | 3 | 104 | 3 | DOID:4362 (implicated_via_orthology) | |
| Disease | NEVUS, EPIDERMAL (disorder) | 4.23e-07 | 5 | 104 | 3 | C0334082 | |
| Disease | Follicular thyroid carcinoma | 4.23e-07 | 5 | 104 | 3 | C0206682 | |
| Disease | Hemimegalencephaly | 8.44e-07 | 6 | 104 | 3 | C0431391 | |
| Disease | RASopathy (implicated_via_orthology) | 3.52e-06 | 9 | 104 | 3 | DOID:0080690 (implicated_via_orthology) | |
| Disease | prostate cancer (implicated_via_orthology) | 5.51e-06 | 33 | 104 | 4 | DOID:10283 (implicated_via_orthology) | |
| Disease | Noonan Syndrome 1 | 6.88e-06 | 11 | 104 | 3 | C4551602 | |
| Disease | Turner Syndrome, Male | 6.88e-06 | 11 | 104 | 3 | C0041409 | |
| Disease | Female Pseudo-Turner Syndrome | 6.88e-06 | 11 | 104 | 3 | C1527404 | |
| Disease | kidney cancer (implicated_via_orthology) | 6.88e-06 | 11 | 104 | 3 | DOID:263 (implicated_via_orthology) | |
| Disease | middle temporal gyrus volume measurement, Alzheimer's disease biomarker measurement | 1.19e-05 | 13 | 104 | 3 | EFO_0006514, EFO_0010316 | |
| Disease | RAS-ASSOCIATED AUTOIMMUNE LEUKOPROLIFERATIVE DISORDER | 1.23e-05 | 2 | 104 | 2 | 614470 | |
| Disease | Autoimmune lymphoproliferative syndrome type 4 | 1.23e-05 | 2 | 104 | 2 | cv:C2674723 | |
| Disease | autoimmune lymphoproliferative syndrome type 4 (is_implicated_in) | 1.23e-05 | 2 | 104 | 2 | DOID:0110117 (is_implicated_in) | |
| Disease | MELANOCYTIC NEVUS SYNDROME, CONGENITAL | 1.23e-05 | 2 | 104 | 2 | 137550 | |
| Disease | Melanocytic nevus | 1.23e-05 | 2 | 104 | 2 | cv:C0027962 | |
| Disease | RAS-ASSOCIATED AUTOIMMUNE LEUKOPROLIFERATIVE DISORDER | 1.23e-05 | 2 | 104 | 2 | C2674723 | |
| Disease | large congenital melanocytic nevus (is_implicated_in) | 1.23e-05 | 2 | 104 | 2 | DOID:0111359 (is_implicated_in) | |
| Disease | Large congenital melanocytic nevus | 1.23e-05 | 2 | 104 | 2 | cv:C1842036 | |
| Disease | Thyroid carcinoma | 1.77e-05 | 44 | 104 | 4 | C0549473 | |
| Disease | RASopathy | 1.88e-05 | 15 | 104 | 3 | cv:C5555857 | |
| Disease | GIANT PIGMENTED HAIRY NEVUS | 3.68e-05 | 3 | 104 | 2 | C1842036 | |
| Disease | Noonan-Like Syndrome With Loose Anagen Hair | 3.96e-05 | 19 | 104 | 3 | C3501846 | |
| Disease | Noonan syndrome-like disorder with loose anagen hair | 3.96e-05 | 19 | 104 | 3 | C1843181 | |
| Disease | Cardio-facio-cutaneous syndrome | 3.96e-05 | 19 | 104 | 3 | C1275081 | |
| Disease | Costello syndrome (disorder) | 3.96e-05 | 19 | 104 | 3 | C0587248 | |
| Disease | leukemia (implicated_via_orthology) | 3.96e-05 | 19 | 104 | 3 | DOID:1240 (implicated_via_orthology) | |
| Disease | LEOPARD Syndrome | 6.24e-05 | 22 | 104 | 3 | C0175704 | |
| Disease | NEVUS, EPIDERMAL | 7.35e-05 | 4 | 104 | 2 | 162900 | |
| Disease | Malignant neoplasm of penis | 7.35e-05 | 4 | 104 | 2 | C0153601 | |
| Disease | Penile Neoplasms | 7.35e-05 | 4 | 104 | 2 | C0030849 | |
| Disease | Nevus, Keratinocytic, Nonepidermolytic | 7.35e-05 | 4 | 104 | 2 | C4011754 | |
| Disease | BLADDER CANCER | 7.35e-05 | 4 | 104 | 2 | 109800 | |
| Disease | Epidermal nevus | 7.35e-05 | 4 | 104 | 2 | cv:C0334082 | |
| Disease | Malignant tumor of urinary bladder | 7.35e-05 | 4 | 104 | 2 | cv:C0005684 | |
| Disease | Thyroid cancer, nonmedullary, 2 | 7.35e-05 | 4 | 104 | 2 | cv:C4225426 | |
| Disease | Malignant tumor of cervix | 7.35e-05 | 4 | 104 | 2 | C0007847 | |
| Disease | epidermal nevus (is_implicated_in) | 7.35e-05 | 4 | 104 | 2 | DOID:0111162 (is_implicated_in) | |
| Disease | THYROID CANCER, NONMEDULLARY, 2 | 7.35e-05 | 4 | 104 | 2 | 188470 | |
| Disease | carcinoma (implicated_via_orthology) | 7.86e-05 | 64 | 104 | 4 | DOID:305 (implicated_via_orthology) | |
| Disease | Noonan Syndrome | 8.16e-05 | 24 | 104 | 3 | C0028326 | |
| Disease | Neoplasms, Experimental | 8.87e-05 | 66 | 104 | 4 | C0027659 | |
| Disease | Disorder of eye | 1.08e-04 | 212 | 104 | 6 | C0015397 | |
| Disease | THYROID CANCER, NONMEDULLARY, 2 | 1.22e-04 | 5 | 104 | 2 | C4225426 | |
| Disease | Malignant neoplasm of thyroid | 1.22e-04 | 5 | 104 | 2 | C0007115 | |
| Disease | Cetuximab response | 1.22e-04 | 5 | 104 | 2 | cv:CN077967 | |
| Disease | Cervix carcinoma | 1.22e-04 | 5 | 104 | 2 | C0302592 | |
| Disease | Panitumumab response | 1.22e-04 | 5 | 104 | 2 | cv:CN077999 | |
| Disease | hypertrophic cardiomyopathy (implicated_via_orthology) | 1.45e-04 | 29 | 104 | 3 | DOID:11984 (implicated_via_orthology) | |
| Disease | colorectal cancer (implicated_via_orthology) | 1.61e-04 | 30 | 104 | 3 | DOID:9256 (implicated_via_orthology) | |
| Disease | Pleocytosis | 1.83e-04 | 6 | 104 | 2 | C0151857 | |
| Disease | Autoimmune lymphoproliferative syndrome | 1.83e-04 | 6 | 104 | 2 | cv:CN301239 | |
| Disease | Carcinoma in situ of uterine cervix | 1.83e-04 | 6 | 104 | 2 | C0851140 | |
| Disease | seminoma (is_implicated_in) | 1.83e-04 | 6 | 104 | 2 | DOID:4440 (is_implicated_in) | |
| Disease | Leukocytosis | 1.83e-04 | 6 | 104 | 2 | C0023518 | |
| Disease | intestinal cancer (implicated_via_orthology) | 1.96e-04 | 32 | 104 | 3 | DOID:10155 (implicated_via_orthology) | |
| Disease | Thyroid cancer, follicular | 2.55e-04 | 7 | 104 | 2 | C2931367 | |
| Disease | Thyroid Neoplasm | 3.03e-04 | 37 | 104 | 3 | C0040136 | |
| Disease | heart disease (implicated_via_orthology) | 3.28e-04 | 38 | 104 | 3 | DOID:114 (implicated_via_orthology) | |
| Disease | Alzheimer's disease biomarker measurement, brain volume measurement | 3.40e-04 | 8 | 104 | 2 | EFO_0006514, EFO_0006930 | |
| Disease | Leukemia, Myelocytic, Acute | 3.76e-04 | 173 | 104 | 5 | C0023467 | |
| Disease | Adenocarcinoma of large intestine | 3.77e-04 | 96 | 104 | 4 | C1319315 | |
| Disease | Neoplasm of uncertain or unknown behavior of breast | 4.11e-04 | 41 | 104 | 3 | C0496956 | |
| Disease | Breast adenocarcinoma | 4.11e-04 | 41 | 104 | 3 | C0858252 | |
| Disease | nephronophthisis (implicated_via_orthology) | 4.36e-04 | 9 | 104 | 2 | DOID:12712 (implicated_via_orthology) | |
| Disease | Noonan syndrome | 4.36e-04 | 9 | 104 | 2 | cv:C0028326 | |
| Disease | high grade glioma (implicated_via_orthology) | 5.07e-04 | 44 | 104 | 3 | DOID:3070 (implicated_via_orthology) | |
| Disease | thyroid gland papillary carcinoma (is_implicated_in) | 5.44e-04 | 10 | 104 | 2 | DOID:3969 (is_implicated_in) | |
| Disease | Neuroblastoma | 6.16e-04 | 47 | 104 | 3 | C0027819 | |
| Disease | entorhinal cortical volume, Alzheimer's disease biomarker measurement | 6.63e-04 | 11 | 104 | 2 | EFO_0005092, EFO_0006514 | |
| Disease | middle temporal gyrus volume measurement | 6.63e-04 | 11 | 104 | 2 | EFO_0010316 | |
| Disease | stomach carcinoma (is_implicated_in) | 7.94e-04 | 12 | 104 | 2 | DOID:5517 (is_implicated_in) | |
| Disease | colorectal cancer (is_implicated_in) | 9.02e-04 | 121 | 104 | 4 | DOID:9256 (is_implicated_in) | |
| Disease | Mouth Neoplasms | 9.26e-04 | 54 | 104 | 3 | C0026640 | |
| Disease | Malignant neoplasm of mouth | 9.26e-04 | 54 | 104 | 3 | C0153381 | |
| Disease | Benign tumor of pancreas | 9.36e-04 | 13 | 104 | 2 | C0347284 | |
| Disease | membranous glomerulonephritis (biomarker_via_orthology) | 1.09e-03 | 14 | 104 | 2 | DOID:10976 (biomarker_via_orthology) | |
| Disease | Malformations of Cortical Development | 1.09e-03 | 14 | 104 | 2 | C1955869 | |
| Disease | whole-brain volume, Alzheimer's disease biomarker measurement | 1.09e-03 | 14 | 104 | 2 | EFO_0005089, EFO_0006514 | |
| Disease | Cortical Dysplasia | 1.09e-03 | 14 | 104 | 2 | C0431380 | |
| Disease | dysmenorrheic pain measurement | 1.43e-03 | 16 | 104 | 2 | EFO_0007889 | |
| Disease | essential hypertension (is_implicated_in) | 1.81e-03 | 18 | 104 | 2 | DOID:10825 (is_implicated_in) | |
| Disease | Hemangiosarcoma | 1.81e-03 | 18 | 104 | 2 | C0018923 | |
| Disease | Pancreatic carcinoma | 2.02e-03 | 19 | 104 | 2 | C0235974 | |
| Disease | familial hyperlipidemia (biomarker_via_orthology) | 2.02e-03 | 19 | 104 | 2 | DOID:1168 (biomarker_via_orthology) | |
| Disease | Juvenile Myelomonocytic Leukemia | 2.02e-03 | 19 | 104 | 2 | C0349639 | |
| Disease | cardiomyopathy (implicated_via_orthology) | 2.04e-03 | 71 | 104 | 3 | DOID:0050700 (implicated_via_orthology) | |
| Disease | Sarcoma | 2.47e-03 | 21 | 104 | 2 | C1261473 | |
| Disease | urinary bladder cancer (is_implicated_in) | 2.48e-03 | 76 | 104 | 3 | DOID:11054 (is_implicated_in) | |
| Disease | Splenomegaly | 2.71e-03 | 22 | 104 | 2 | C0038002 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| MLYITCFREIAERMA | 706 | Q7Z4L5 | |
| LRTFRKMSCYIMQDD | 136 | Q9H172 | |
| RKYAAMVTCMDEAVR | 261 | Q5FYB1 | |
| SLACGLRILFRMYMD | 1726 | Q9Y6D6 | |
| CYVDDIFLRVMSRSM | 626 | O95477 | |
| MSRLETEMESYRCRL | 646 | A6NC57 | |
| NVYGFDMTCIRDVAM | 241 | Q9NR22 | |
| MLRMLLNYGYDTERC | 436 | A6NK59 | |
| TVLRYMTDGMLLREF | 491 | O60231 | |
| FTRRGEDLFMCMDIQ | 251 | P31689 | |
| LPAAYCERAMMRFSE | 1011 | Q6W2J9 | |
| MLSDDVCQLMLIRYG | 621 | A8MX76 | |
| MVRLIYCEMLGYDAS | 81 | Q9UPM8 | |
| LMDLDVVMRSSDCPY | 146 | P45985 | |
| AMRDQYMRTGEGFLC | 66 | P01112 | |
| AMRDQYMRTGEGFLC | 66 | P01116 | |
| AMRDQYMRTGEGFLC | 66 | P01111 | |
| MSMGYERERVVAALR | 171 | P54725 | |
| FEAVGRIYELRLMMD | 91 | A0AV96 | |
| FSKFGEIRECMVMRD | 41 | Q96DH6 | |
| EGLDMQMIIYRCLST | 946 | O75747 | |
| LFKEMCYRYREDLMA | 116 | P28072 | |
| YRREMDPEIDIMCTG | 1881 | Q14571 | |
| IERMARADRFLYEMS | 736 | Q86T65 | |
| LACDRFLKVYDLRMM | 261 | Q504Q3 | |
| ECFLLGMMAFDRYVA | 111 | Q8NGS5 | |
| TECVLLSMMAFDRYV | 111 | Q8NH95 | |
| TECVLLSMMAFDRYV | 111 | P0DN81 | |
| SMLDILMDYCHLRDF | 626 | Q9NRZ9 | |
| MTMESREMDCYLRRL | 1 | Q9NTI7 | |
| GRYEELARMLMGLDL | 56 | Q99685 | |
| RLGLMEMIAFARIFC | 231 | Q8N335 | |
| MRSLECASMDYEAPL | 1381 | O60303 | |
| YRSYFMECLVDARML | 961 | O75335 | |
| MDPRMLVSCIDFRYI | 141 | Q7L5Y1 | |
| CFLLQADRMSLFMYR | 86 | P16499 | |
| ANECASRLMYGMELD | 501 | Q8NA70 | |
| MISLDRYCAVMDPLR | 111 | P25021 | |
| RSYFMECLVDARMLD | 981 | Q13136 | |
| MFCVLYPENIEARDM | 111 | Q9UL01 | |
| TTAACMMDLRRYPLD | 156 | P47870 | |
| ICELMDMNIYELIRG | 81 | Q9UQ07 | |
| TECLLLSMMAFDRYV | 111 | Q9NQN1 | |
| ECVLLGMMAFDRYVA | 111 | Q8NGS9 | |
| ILLAVMSFDRYMAIC | 111 | Q8NGM8 | |
| FRCMDVDGDGVLSMY | 981 | Q06190 | |
| VMFGCDMESIRRIFE | 326 | Q8TCU5 | |
| IYGLVAELRSERMCM | 2261 | Q9UMZ3 | |
| RTGCYIVLDVMLDMA | 1091 | Q92729 | |
| LERDQMSMEGFSRYL | 286 | Q01970 | |
| EIMCMIRDFRGSLDY | 196 | O00139 | |
| SSECQGEMLDYRRML | 416 | Q92896 | |
| GEMLDYRRMLMEDFS | 421 | Q92896 | |
| LMERLLDYRDCMKGE | 1196 | Q8IZD9 | |
| RLLDYRDCMKMGEVD | 1161 | Q8N1I0 | |
| RLLQETLYMCVGIMD | 181 | O95067 | |
| TGVMSRRYLCMDFRG | 86 | Q9GZV9 | |
| NSLDVDMRGLFDYMC | 231 | Q9P203 | |
| TCRCFDGYRLDMTRM | 1556 | Q8N2S1 | |
| DGYRLDMTRMACVDI | 1561 | Q8N2S1 | |
| RLTGMRFEAMERYDD | 91 | Q15006 | |
| ETIRVCYFMERLMAR | 2456 | Q9NYC9 | |
| LREYMCVDRSAAMLV | 211 | Q9H7H0 | |
| FYLGSFDSIVRRCMM | 306 | Q06136 | |
| FPIGRRDFDMLRCML | 141 | P20382 | |
| RDFDMLRCMLGRVYR | 146 | P20382 | |
| CLTYEASMTRMFREG | 586 | Q92523 | |
| RDAMMAKAEYLCRIG | 101 | Q15008 | |
| ECLLLGMMAFDRYVA | 141 | Q8NGS6 | |
| ECMILGTMALDRYVA | 111 | Q8NGS7 | |
| ECVLLGMMAFDRYVA | 111 | Q8NGT0 | |
| IRECVICMMDFVYGD | 96 | Q9Y3C5 | |
| IFCMEQEREMKYSRA | 841 | Q92750 | |
| NRMYSDRKGCFDRAM | 1961 | P46939 | |
| RACLGDLRDMISMYL | 391 | P41225 | |
| VFLCLTRYIGDSMVM | 421 | Q8N135 | |
| MTMSGERECLKYRLV | 131 | Q13200 | |
| ACEGRMLETFLTYPM | 371 | O14827 | |
| REMDVTKVCGEMRYQ | 446 | Q86SQ7 | |
| VMDCKMGIRTYLEEE | 741 | P27987 | |
| DAMGEIKDCSRYMAR | 451 | Q5QGS0 | |
| MSFDRYIALARAMRC | 151 | Q99527 | |
| EMLCMGFFTLEYLLR | 306 | Q8TDN2 | |
| ILRGANDFMCDEMER | 376 | P17987 | |
| DRFMDDIACMIGYRP | 501 | P48029 | |
| INCLMRAIEIYTDMG | 101 | P54920 | |
| CMYSMSDVRRVFLGP | 341 | Q14563 | |
| AGMLSYFLFEELMRC | 71 | Q9BWW9 | |
| CLGEAMARMELFLYF | 91 | Q6ZSU1 | |
| EFEALMRMLDNLGYR | 376 | P35611 | |
| GECNVMLESRFEKMY | 971 | Q6P2Q9 | |
| YMGCVEVLQSMRSLD | 196 | Q6S5L8 | |
| EEEGCMEYMRGLLRD | 441 | O94827 | |
| DSSCMLYDIRGGRMV | 821 | O94967 | |
| MDGLRRRVYQGMLDC | 231 | Q8N413 | |
| YRRKMEGTSINFCME | 281 | O00338 | |
| MEDLVCYSFQVARGM | 1011 | P35916 | |
| IFCFRGDSLMDMYTL | 326 | Q8NE00 | |
| DFNYGVCVMRMREGL | 766 | P55017 | |
| ACDMAGAAMYELVRV | 31 | P38606 | |
| PMCREFFSERADLFM | 6 | Q8N3J9 | |
| RGQYEMLSECLERAM | 376 | Q86TV6 | |
| YVMLSECLERAMKFA | 396 | Q9ULT0 | |
| LSAMISPRDEDMLCY | 206 | Q9H489 | |
| TCVRTMMFLAEHDYG | 1346 | Q69YN4 | |
| LSVDPYMRCRMNEDT | 46 | Q8N8N7 | |
| YMRCRMNEDTGTDYI | 51 | Q8N8N7 | |
| DYVCERMLEFLMGAA | 1451 | O60293 | |
| YMGCVEVLQSMRALD | 166 | P29353 | |
| TLIRFMVDIACGMEY | 631 | Q06418 | |
| MVDIACGMEYLSSRN | 636 | Q06418 | |
| ELTETCLDMMARYVF | 1021 | P49815 | |
| ELMGSMERYDSICNV | 396 | Q2WGJ6 | |
| LYCSARAIGMADMTR | 731 | Q92539 |